These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8274187)

  • 1. Does endogenous glycosylation prevent the use of mouse monoclonal antibodies as cancer therapeutics?
    Borrebaeck CK; Malmborg AC; Ohlin M
    Immunol Today; 1993 Oct; 14(10):477-9. PubMed ID: 8274187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of plasmapheresis and deoxyspergualin or cyclophosphamide treatment on anti-porcine Gal-alpha (1,3)-Gal antibody titres in humans.
    Gannedahl G; Tufveson G; Sundberg B; Groth CG
    Transplant Proc; 1996 Apr; 28(2):551. PubMed ID: 8623262
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical analysis of pig xenoantigens detected by human antibodies.
    Vaughan HA; Dabkowski PL; McKenzie IF; Sandrin MS
    Transplant Proc; 1993 Oct; 25(5):2919-20. PubMed ID: 7692648
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of xenoreactive natural antibodies: interactions with carbohydrate determinants.
    Parker W; Lateef J; Everett ML; Bruno D; Platt JL
    Transplant Proc; 1996 Apr; 28(2):548. PubMed ID: 8623260
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse.
    Nozawa S; Xing PX; Wu GD; Gochi E; Kearns-Jonker M; Swensson J; Starnes VA; Sandrin MS; McKenzie IF; Cramer DV
    Transplantation; 2001 Jul; 72(1):147-55. PubMed ID: 11468550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on human naturally occurring antibodies to pig xenografts.
    Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF
    Transplant Proc; 1993 Oct; 25(5):2917-8. PubMed ID: 7692647
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the human alpha 1,3Gal-reactive natural antibody population.
    McMorrow IM; Comrack C; Sachs DH; Monroy R; DerSimonian H
    Transplant Proc; 1996 Apr; 28(2):547. PubMed ID: 8623259
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of different synthetic oligosaccharides for blocking the natural anti-g Gal antibodies found in human and baboon sera.
    Oriol R; Neethling F; Joziasse D; Bovin N; Cooper DK
    Transplant Proc; 1996 Apr; 28(2):562. PubMed ID: 8623272
    [No Abstract]   [Full Text] [Related]  

  • 9. Human naturally occurring antibodies to pig xenografts.
    Sandrin MS; Vaughan HA; Dabkowski PL; McKenzie IF
    Transplant Proc; 1994 Jun; 26(3):1392. PubMed ID: 7518133
    [No Abstract]   [Full Text] [Related]  

  • 10. Human urinary bladder carcinoma glycoconjugates expressing T-(Gal beta(1-3)GalNAc alpha 1-O-R) and T-like antigens: a comparative study using peanut agglutinin and poly- and monoclonal antibodies.
    Langkilde NC; Wolf H; Clausen H; Orntoft TF
    Cancer Res; 1992 Sep; 52(18):5030-6. PubMed ID: 1516058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical potential of xenotransplantation.
    Cooper DK; Koren E; Oriol R
    Transplant Proc; 1994 Jun; 26(3):1331-2. PubMed ID: 7518129
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
    Liu L
    J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of xenoreactive anti-Gal alpha 1-3Gal IgM for alpha-galactosyl ligands.
    Parker W; Lateef J; Everett ML; Platt JL
    Glycobiology; 1996 Jul; 6(5):499-506. PubMed ID: 8877370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thomsen-Friedenreich and PK antigens in pig-to-human xenotransplantation.
    Cairns T; Lee J; Goldberg LC; Hakim N; Cook T; Rydberg L; Samuelsson B; Taube D
    Transplant Proc; 1996 Apr; 28(2):795-6. PubMed ID: 8623404
    [No Abstract]   [Full Text] [Related]  

  • 15. Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes.
    Pitre J; Möller E; Satake M
    Transplant Proc; 1996 Apr; 28(2):545. PubMed ID: 8623257
    [No Abstract]   [Full Text] [Related]  

  • 16. Fetal pig xenografts in NOD/Lt mice: lack of expression of Gal(alpha 1-3)Gal on endocrine cells and the effect of peritransplant anti-CD4 monoclonal antibody and graft immunomodification on graft survival.
    Koulmanda M; McKenzie I; Sandrin M; Mandel T
    Transplant Proc; 1995 Dec; 27(6):3570. PubMed ID: 8540106
    [No Abstract]   [Full Text] [Related]  

  • 17. The humoral immune response in humans following ex vivo perfusion of porcine livers.
    Cotterell AH; Collins BH; Parker W; Harland RC; Platt JL
    Transplant Proc; 1996 Apr; 28(2):546. PubMed ID: 8623258
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferences with two-site immunoassays by human anti-mouse antibodies formed by patients treated with monoclonal antibodies: comparison of different blocking reagents.
    Reinsberg J
    Clin Chem; 1998 Aug; 44(8 Pt 1):1742-4. PubMed ID: 9702964
    [No Abstract]   [Full Text] [Related]  

  • 19. Binding specificity for four monoclonal antibodies recognizing terminal Gal alpha 1-->4Gal residues in Haemophilus influenzae lipopolysaccharide.
    Borrelli S; Altmann K; Jansson PE; Lindberg AA
    Microb Pathog; 1995 Sep; 19(3):139-57. PubMed ID: 8559043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC; Johnson PW; Glennie MJ
    Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.